S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

Cerence Stock Forecast, Price & News

-0.14 (-0.15 %)
(As of 10/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume194,700 shs
Average Volume537,560 shs
Market Capitalization$3.59 billion
P/E Ratio82.94
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CRNC News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerence and its competitors with MarketBeat's FREE daily newsletter.

Cerence logo

About Cerence

Cerence Inc. provides AI-powered assistants and innovations for connected and autonomous vehicles It offers edge software components; cloud-connected components; toolkits; applications; and virtual assistant coexistence and professional services. The company also provides conversational artificial intelligence, including voice recognition, natural language understanding, and artificial intelligence services. Cerence Inc. is headquartered in Burlington, Massachusetts.


See More Headlines

Industry, Sector and Symbol

Prepackaged software
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$329.65 million
Cash Flow
$0.26 per share
Book Value
$26.08 per share


Net Income
$-20.63 million




Market Cap
$3.59 billion
Next Earnings Date
11/15/2021 (Estimated)
Not Optionable


Overall MarketRank

2.76 out of 5 stars

Computer And Technology Sector

58th out of 866 stocks

Prepackaged Software Industry

10th out of 258 stocks

Analyst Opinion: 4.4Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -

Cerence (NASDAQ:CRNC) Frequently Asked Questions

Is Cerence a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cerence in the last twelve months. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cerence stock.
View analyst ratings for Cerence
or view top-rated stocks.

What stocks does MarketBeat like better than Cerence?

Wall Street analysts have given Cerence a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cerence wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cerence's next earnings date?

Cerence is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for Cerence

How were Cerence's earnings last quarter?

Cerence Inc. (NASDAQ:CRNC) announced its earnings results on Sunday, August, 8th. The company reported $0.62 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.54 by $0.08. The company earned $96.80 million during the quarter, compared to analyst estimates of $95.96 million. Cerence had a trailing twelve-month return on equity of 5.44% and a net margin of 11.91%. The company's revenue for the quarter was up 28.7% on a year-over-year basis. During the same quarter last year, the company posted $0.32 EPS.
View Cerence's earnings history

How has Cerence's stock price been impacted by Coronavirus?

Cerence's stock was trading at $18.61 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CRNC stock has increased by 408.1% and is now trading at $94.55.
View which stocks have been most impacted by COVID-19

What guidance has Cerence issued on next quarter's earnings?

Cerence issued an update on its fourth quarter 2021 earnings guidance on Monday, September, 6th. The company provided earnings per share (EPS) guidance of $0.550-$0.610 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.530. The company issued revenue guidance of $97 million-$101 million, compared to the consensus revenue estimate of $98.40 million.

What price target have analysts set for CRNC?

11 analysts have issued 1-year price objectives for Cerence's shares. Their forecasts range from $82.00 to $165.00. On average, they anticipate Cerence's stock price to reach $125.82 in the next year. This suggests a possible upside of 33.1% from the stock's current price.
View analysts' price targets for Cerence
or view top-rated stocks among Wall Street analysts.

Who are Cerence's key executives?

Cerence's management team includes the following people:
  • Mr. Sanjay Dhawan, CEO & Director (Age 57, Pay $1.48M) (LinkedIn Profile)
  • Mr. Mark J. Gallenberger, Chief Financial Officer (Age 57, Pay $838.32k)
  • Dr. Stefan Ortmanns, Exec. VP of Core Automotive (Age 57, Pay $1.43M) (LinkedIn Profile)
  • Mr. Prateek Kathpal, Chief Technology Officer
  • Ms. Bridget Collins, Chief Information Officer
  • Mr. Richard Yerganian, VP of Investor Relations
  • Ms. Leanne Fitzgerald, Gen. Counsel & Sec. (Age 56)
  • Mr. Egon Jungheim, Sr. VP Global Sales
  • Mr. Richard Mack, Chief Marketing Officer
  • Mr. Sachin Sahney, Chief HR Officer

What other stocks do shareholders of Cerence own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cerence investors own include NVIDIA (NVDA), Square (SQ), Fastly (FSLY), DocuSign (DOCU), PayPal (PYPL), Shopify (SHOP), Teladoc Health (TDOC), Alteryx (AYX), Lumentum (LITE) and salesforce.com (CRM).

What is Cerence's stock symbol?

Cerence trades on the NASDAQ under the ticker symbol "CRNC."

Who are Cerence's major shareholders?

Cerence's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pinnacle Associates Ltd. (0.28%), Prentiss Smith & Co. Inc. (0.20%), Hohimer Wealth Management LLC (0.07%), Oregon Public Employees Retirement Fund (0.03%), Louisiana State Employees Retirement System (0.03%) and Kestra Advisory Services LLC (0.03%). Company insiders that own Cerence stock include Kristi Ann Matus, Leanne Fitzgerald, Mark J Gallenberger, Sanjay Dhawan, Stefan Ortmanns and Thomas L Beaudoin.
View institutional ownership trends for Cerence

Which institutional investors are selling Cerence stock?

CRNC stock was sold by a variety of institutional investors in the last quarter, including Vivid Financial Management Inc., Strs Ohio, Hohimer Wealth Management LLC, Farmers & Merchants Investments Inc., Kestra Advisory Services LLC, and Wedbush Securities Inc.. Company insiders that have sold Cerence company stock in the last year include Kristi Ann Matus, Leanne Fitzgerald, Sanjay Dhawan, Stefan Ortmanns, and Thomas L Beaudoin.
View insider buying and selling activity for Cerence
or view top insider-selling stocks.

Which institutional investors are buying Cerence stock?

CRNC stock was acquired by a variety of institutional investors in the last quarter, including Pinnacle Associates Ltd., Oregon Public Employees Retirement Fund, Louisiana State Employees Retirement System, Wesbanco Bank Inc., New Mexico Educational Retirement Board, Crossmark Global Holdings Inc., State of Alaska Department of Revenue, and Pacer Advisors Inc..
View insider buying and selling activity for Cerence
or or view top insider-buying stocks.

How do I buy shares of Cerence?

Shares of CRNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cerence's stock price today?

One share of CRNC stock can currently be purchased for approximately $94.55.

How much money does Cerence make?

Cerence has a market capitalization of $3.59 billion and generates $329.65 million in revenue each year. The company earns $-20.63 million in net income (profit) each year or ($0.57) on an earnings per share basis.

How many employees does Cerence have?

Cerence employs 1,500 workers across the globe.

What is Cerence's official website?

The official website for Cerence is www.cerence.com.

Where are Cerence's headquarters?

Cerence is headquartered at 15 WAYSIDE ROAD, BURLINGTON MA, 01803.

How can I contact Cerence?

Cerence's mailing address is 15 WAYSIDE ROAD, BURLINGTON MA, 01803. The company can be reached via phone at 857-362-7300 or via email at [email protected].

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.